NEWS & EVENTS
-
-
-
April 17, 2025
GemPharmatech Significantly Expands U.S. Capabilities with New San Diego Biotech Hub Facility
GemPharmatech, a global leader in genetically engineered mouse models and preclinical contract research services, today announced the grand opening of its newly expanded U.S. headquarters in San Diego's premier biotech corridor, marking a significant milestone in the company's North American expansion strategy.
-
-
-
-
April 01, 2025
GemPharmatech Joins Shonan Health Innovation Park, Expanding and Strengthening Research Support in Japan
GemPharmatech, a global leader in genetically engineered mouse models and preclinical research services, today announced its official entry into Shonan Health Innovation Park (Shonan iPark). This strategic move marks a significant milestone in the company's expansion into the Japanese market and reinforces it commitment to advancing biomedical research and innovation worldwide.
-
-
-
-
February 27, 2025
GemPharmatech and Goodwill Announce Strategic Partnership to Advance AI-Driven PDX Model Ecosystem for Cancer Drug Development
GemPharmatech Co., Ltd., a global leader in mouse model development and preclinical research services, has entered into a comprehensive strategic partnership with Goodwill E-Health Info Co., Ltd., a pioneer in clinical data governance and medical AI. The collaboration aims to create a cutting-edge, AI-enhanced Patient-Derived Xenograft (PDX) model database to accelerate cancer treatment innovation and translational medicine.
-
-
-
-
November 13, 2024
GemPharmatech Named One of China’s Top 100 Life Science Service Brands for 2024
GemPharmatech has been named one of the “Top 100 Brands of Chinese Life Science Service Enterprises” for 2024 by Healthcare Executive, a leading voice in China’s pharmaceutical industry. The recognition highlights GemPharmatech’s growing influence as a trusted research partner in China’s rapidly advancing biotech landscape.
-
-
-
-
September 13, 2023
GemPharmatech's Board Appoints Brandy Wilkinson, Ph.D. as its New Chief Executive Officer of GemPharmatech LLC.
GemPharmatech LLC., a leading contract research organization, announced today that its Board of Directors has appointed Dr. Brandy Wilkinson as the Chief Executive Officer of its subsidiary in the United States, effective September 12, 2023.
-
